← Back

US Federal Register - FDA Notices · United States · 9 Oct 2026 · Rule change

Withdrawal of Approval of 37 Abbreviated New Drug Applications

The Food and Drug Administration (FDA or Agency) is withdrawing approval of 37 abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.